HomeCompareZDVSV vs JNJ

ZDVSV vs JNJ: Dividend Comparison 2026

ZDVSV yields 0.23% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $10.3K in total portfolio value· pulled ahead in Year 5
10 years
ZDVSV
ZDVSV
● Live price
0.23%
Share price
$123.00
Annual div
$0.29
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$23.52
Full ZDVSV calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — ZDVSV vs JNJ

📍 JNJ pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZDVSVJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZDVSV + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ZDVSV pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZDVSV
Annual income on $10K today (after 15% tax)
$19.70/yr
After 10yr DRIP, annual income (after tax)
$19.99/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $3,966.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZDVSV + JNJ for your $10,000?

ZDVSV: 50%JNJ: 50%
100% JNJ50/50100% ZDVSV
Portfolio after 10yr
$25.1K
Annual income
$2,356.46/yr
Blended yield
9.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ZDVSV
Analyst Ratings
9
Buy
2
Hold
Consensus: Buy
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZDVSV buys
0
JNJ buys
0
No recent congressional trades found for ZDVSV or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZDVSVJNJ
Forward yield0.23%2.13%
Annual dividend / share$0.29$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$20.0K$30.3K
Annual income after 10y$23.52$4,689.40
Total dividends collected$234.00$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: ZDVSV vs JNJ ($10,000, DRIP)

YearZDVSV PortfolioZDVSV Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,723$23.17$10,592$272.30+$131.00ZDVSV
2$11,497$23.22$11,289$357.73+$208.00ZDVSV
3$12,325$23.27$12,123$472.89+$202.00ZDVSV
4$13,211$23.31$13,141$629.86+$70.00ZDVSV
5← crossover$14,159$23.35$14,408$846.81$249.00JNJ
6$15,174$23.39$16,021$1,151.60$847.00JNJ
7$16,259$23.43$18,122$1,588.22$1.9KJNJ
8$17,421$23.46$20,930$2,228.20$3.5KJNJ
9$18,664$23.49$24,792$3,191.91$6.1KJNJ
10$19,994$23.52$30,274$4,689.40$10.3KJNJ

ZDVSV vs JNJ: Complete Analysis 2026

ZDVSVStock

J2 Global, Inc. provides internet services worldwide. It operates through three segments: Fax and Martech; Voice, Backup, Security, and Consumer Privacy and Protection; and Digital Media. The company offers cloud services, which include cloud fax services under the eFax, sFax, SRFax, MyFax, and eFax Corporate brands; endpoint and email security, and threat intelligence services for real-time malware analysis under the VIPRE brand; Inspired eLearning, a SaaS platform for cybersecurity awareness and compliance training; virtual private network services under the IPVanish and Encrypt.me names; online file backup, synchronization, and sharing services under the SugarSync name; and online backup and sync storage services under the LiveDrive name. It also provides email marketing and delivery solutions under the Campaigner, iContact, and SMTP names; on-demand voice communications services under the eVoice name; cloud phone communications services under theLine2 names; and IP licensing services. In addition, the company operates a portfolio of web properties and apps, including IGN, RetailMeNot, Mashable, PCMag, Humble Bundle, Speedtest, Offers, Black Friday, MedPageToday, Everyday Health, BabyCenter, and What to Expect, and others that offer technology products, gaming and lifestyle products and services, news and commentary related products, speed testing for internet and network connections, online deals and discounts for consumers, news, interactive tools and mobile applications, and tools and information for healthcare professionals, as well as professional networking tools, targeted emails, and white papers for IT professionals. It serves sole proprietors, small to medium-sized businesses, enterprises, and government organizations. The company was formerly known as j2 Global Communications, Inc. and changed its name to j2 Global, Inc. in December 2011. J2 Global, Inc. was founded in 1995 and is headquartered in Los Angeles, California.

Full ZDVSV Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this ZDVSV vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZDVSV vs SCHDZDVSV vs JEPIZDVSV vs OZDVSV vs KOZDVSV vs MAINZDVSV vs ABBVZDVSV vs MRKZDVSV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.